Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|February 4, 2021
ERK Inhibitor LY3214996-Based Treatment Strategies for RAS-Driven Lung CancerJens Köhler, Yutong Zhao, Jiaqi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non-Small Cell Lung CancerElena Ivanova, Mari Kuraguchi, Man Xu, et al.
Applied and Environmental Microbiology|September 19, 2025
Evidence of ESBL plasmid transfer and selective persistence of multiple host-associated Escherichia coli isolates in a chicken cecal fermentation modelJ Leng, M Ferrandis-Vila, R Oldenkamp, et al.
Scientific Reports|April 3, 2025
Results of a multicenter, randomized trial examining a new transition model for post-kidney transplant adolescentsMartin Kreuzer, Jenny Prüfe, Marie-Luise Dierks, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 4, 2025
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLCSeshiru Nakazawa, Federica Pecci, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLCGonzalo Recondo, Magda Bahcall, Liam F Spurr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Pageof 19